In a later study, VEGF supplementation was further found to reduce caspase-3 levels and restore the expression of calbindin-D28K expression following ALS-CSF exposure, the latter possibly contributing to improved calcium buffering capacity (Vijayalakshmi et al., 2015). Here, VEGFA is linked to amyotrophic lateral sclerosis.